(FM) Oncología
Departamento académico
University of Bergen
Bergen, NoruegaUniversity of Bergen-ko ikertzaileekin lankidetzan egindako argitalpenak (1)
2020
-
Final results from GCIG/ENGOT/AGO-OVAR 12, a randomised placebo-controlled phase III trial of nintedanib combined with chemotherapy for newly diagnosed advanced ovarian cancer
International Journal of Cancer, Vol. 146, Núm. 2, pp. 439-448